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the previously established correlation patterns, the 
measurement can be considered problematic, and the most 
probable parameter fingerprint can be determined by mixing 
the base fingerprints. 
 
Results: Parameter fingerprints for the most frequent 
energies of Varian and Elekta linacs were generated and used 
to validate BBD. The method is very sensitive to problems 
with depth-dose curves (DDC), e.g. incorrect placement of 
the sensitive volume of the detector, spectral dependencies 
of the detector for large fields/large depths, partial-volume-, 
cable- and scatter-effects. Due to the virtually absent scatter 
in small fields, MC is the ideal method to augment and 
validate the self-consistency of small field dosimetry. The 
precision of error detection is in the range of 0.1 mm 
detector position shifts and 0.3% dose error, for DDC from 
5x5 mm² to 400x400 mm². Output factor variations can be 
detected with a sensitivity of 0.2%, MLC positioning 
uncertainty with a sensitivity of 0.1 mm. Typical issues with 
detector types and accelerator models can be identified. 
 
Conclusion: Monte-Carlo derived phase space abstractions 
can be used to validate the self-consistency and overall 
quality of base data measurements and thereby fill a gap in 
the quality assurance chain. Base data can be validated with 
an accuracy of 0.3%, being one order of magnitude better 
than potential experimental errors. 
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Purpose or Objective: To evaluate the accuracy of the 
CyberKnife Synchrony Respiratory Tracking System (RTS) and 
to validate a method for pre-treatment patient-specific 
delivery quality assurance (DQA). 
 
Material and Methods: An EasyCube Phantom (Sun Nuclear), 
consisting of RW3 slabs, was mounted on the ExacTrac (ET) 
Gating Phantom (Brainlab), which can move along the 
superior-inferior axis of the patient to simulate a moving 
target. Eight fiducial markers were implanted in the 
EasyCube for the treatment set-up and for the tracking. A 
Gafchromic EBT3 film (Ashland) was positioned between two 
slabs of the EasyCube, while a PinPoint ionization chamber 
(PTW) was placed in an appropriate insert. The EBT3 films 
were calibrated with a 6MV beam (Trilogy, Varian) from 0 to 
15 Gy and analysed with the multichannel film dosimetry 
performed by the FilmQA Pro software (Ashland). Our 
evaluation was performed in two steps: 1) the films were 
irradiated with single fields perpendicular to the EasyCube 
for several collimators (3 fixed collimators: 15, 30, 60mm; 3 
IRIS openings: 20, 30 and 40mm) and in different dynamic 
conditions (e.g. motion amplitude of the ET Phantom from 8 
to 28 mm). The delivered and planned dose distributions 
were compared with the gamma (γ) analysis method. The 
local γ passing rates (GP) were evaluated using 3 acceptance 
criteria, varying the local dose difference (LDD), the 
distance-to-agreement (DTA) and the dose threshold (TH): 
3%/3mm TH=10%, 2%/2mm TH=30% and 3%/1mm 
TH=50%.Dynamic cases were also delivered with purposefully 
simulated errors (RTS switched off or low coverage of the 
respiratory correlation model). 2) The DQA plans of 6 clinical 
patients were delivered in different dynamic conditions, for a 
total of 19 cases. The measured and planned dose 
distributions were evaluated with the same γ-index criteria 
of step 1 and the measured PinPoint doses were compared 
with the planned mean doses in the sensitive volume of the 
chamber. 
 
 
The test was considered passed if the 3 γ analysis criteria 
yielded a GP>90% or at least 2 criteria yielded a GP>90% and 
the PinPoint dose difference (ΔD) was <5.0%. 
 
Results: The γ analysis of the collimators showed the need to 
use more γ-index criteria to detect the simulated errors. 
Only the stricter DTA criterion drastically failed the test, 
with GP<70%. All of the DQA plans passed the tests, both in 
static and dynamic conditions. The mean GP (±σ) were 
95.5±5.2% (3%/3mm), 98.6±1.4% (2%/2mm) and 97.8±2.2% 
(3%/1mm).The mean ΔD was 2.9±1.8%. No significant 
differences were found between the static and the dynamic 
cases. 
 
Conclusion: The presented method confirms the ability of 
the RTS, if used properly, to treat a moving target with great 
precision. Our pre-treatment patient-specific DQA method 
was robust, combining PinPoint dose measurements and an 
evaluation of dose distributions with EBT3 films. However, 
we found the need of a detailed study of each case, 
especially when one acceptance criterion does not satisfy the 
tolerance level. 
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Purpose or Objective: Apply a validated Monte Carlo (MC) 
tool for independent dose calculation in proton PBS to 
‘patient specific’ quality assurance (QA) tasks 
 
Material and Methods: We had developedand validated a MC 
tool for independent dose calculation[1]. In this work weuse 
this code for: 
- Recalculationof a clinically approved plan from the TPS, to 
evaluate the quality of our TPSsemi-analytical dose 
calculation algorithm at the level of the individualpatient 
- Recalculationof a treatment session using the Log File 
coming from the Therapy ControlSystem (TCS), to evaluate 
differences in 3D dose distribution in patientanatomy taking 
into account the characteristics of spots (energy, position, 
MUetc.) as actually delivered by the machine 
- Simulationof a 2D patient specific QA (2DQA). 
This is aretrospective study on 10 patients done to evaluate 
the possibility ofsubstituting our actual 2DQA measurement 
process with a completely automatic andreliable MC based 
workflow. For each 2DQA TPS and MC dose 
distributionsrecalculated in water equivalent material, at 
different depths, were comparedwith measurements 
performed with an array of 1020 ionization chambers 
